Skip to main content

Table 2 Effect of ECN (10 mg/kg) on the liver and renal function test following CFA-induced arthritis

From: RETRACTED ARTICLE: Suppression of NF-κB signaling by ECN in an arthritic model of inflammation

Parameters

ALT (IU/L)

AST (IU/L)

Creatinine (mg/dl)

Normal control

25.33 ± 0.57

21.33 ± 0.57

1.09 ± 1.73

CFA

37.33 ± 1.52###

35.66 ± 3.51###

1.50 ± 4.04###

ECN (10 mg/kg)

30.81 ± 4.35

25.5 ± 2.64

1.20 ± 0.57

  1. The results revealed no marked changes in the LFTs and RFTs in any group. The data were represented as the mean ± SD (n = 7). (*) p < 0.05, (**) p < 0.01 and (***) p < 0.001 indicates significant differences from the CFA control group, while (###) means comparison with the CFA treated group
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us